Medtronic Completes Scientia Vascular Acquisition
Summary
Medtronic has finalized its acquisition of Scientia Vascular. This move expands the company's product portfolio, likely enhancing its offerings within the vascular device market. The completion of this deal represents a concrete step in Medtronic's ongoing strategic development.
At the time of this announcement, MDT was trading at $80.22 on NYSE in the Life Sciences sector, with a market capitalization of approximately $103B. The 52-week trading range was $73.31 to $106.33. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.